ARCHIVES

In the States: Georgia Requires Coverage Of Routine Costs For Children In Clinical Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 32 | August 14, 1998

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014